论文信息 - First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study - 字舞流文

First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study

E. Van Cutsem | H. Lenz | B. Neyns | M. Overman | M. Aglietta | G. Luppi | S. Lonardi | T. Dragovich | A. Hendlisz | D. Cardin | U. Shah | P. García-Alfonso | K. Wong | J. Ledeine | J. Gricar | S. Abdullaev | Maria Luisa Limon | Sandzhar Abdullaev